"The LOI provides for a potential investment of up to S$20m by a significant Asian Life Sciences fund."
"In return for this A$15m of funding the investors will acquire a 30% interest in PrIME. A further 10% of PrIME will be issued to Luye in return for the Singapore
cGMP facility, leaving NuSep with a 60% ownership of PrIME. The A$50m valuation of PrIME is an agreed valuation which is further supported by an independent valuation of PrIME
commissioned by NuSep in May 2012."
23c per share will be confirmed soon, without adding the India branch with should bring another 10c per share.
China,
Philippine,
Vietnam,
.......
Looking at $1.0 per share in 3 years time.
To realize $1.0 per share, NSP just need to make $10-15m net profits per year. quite achievable IMV.
"The LOI provides for a potential investment of up to S$20m by a...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $25.15K | 5.030M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 18776263 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 10551662 | 4 |
View Market Depth
| Last trade - 10.32am 08/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
